Close Menu

CPTAC

The CPTC initiative aims to offer one award for a base period of one year plus four one-year options to develop and maintain a data center in support of the second phase of the project, in which six to eight teams will molecularly characterize four to six tumor types.

The call for targets, from which CPTC expects to select 40 to 50 proteins for antibody development, is part of a pilot effort exploring the organization's ability to receive and process such requests from the extramural research community.

The work will focus on developing antibodies to tryptic peptides derived from protein biomarkers in human plasma for mass spec workflows like SISCAPA and immuno-MALDI.

With most presentations avoiding promises of immediate clinical utility, post-translational modifications emerged as a primary area of consideration at the initiative's annual meeting, held this week in Bethesda, Md.

Pages

Facebook has developed an artificial intelligence approach to predict how drugs interact in cells, New Scientist reports.

In PNAS this week: adaptations among high-altitude Mycobacterium tuberculosis, response of multiple myeloma cells to chemotherapy-induced stress, and more.

Italy has held talks with vaccine developers to manufacture mRNA-based SARS-CoV-2 vaccines, according to the Financial Times.

The Associated Press reports US officials are removing restrictions on fetal tissue research that were added during the Trump Administration.